Antioxidant agents driving the upregulation of HO-1, such as dimethyl fumarate [50], gastrodin [51], and thioredoxin [52], have been reported beneficial in models of stroke and also reduce microglial activation and stroke-related neuroinflammation. This evidence concerns the gene HMOX1 and Stroke.